So I keep seeing people ask me if pot stocks will ever recover, and honestly, it's a question worth revisiting right now. These cannabis plays have been an absolute bloodbath for anyone who bought in during the hype years. The MSOS ETF is down 77% over the past five years while the S&P 500 basically doubled. That's brutal.

But here's what's got people talking again lately. There's been serious discussion about rescheduling cannabis at the federal level - potentially moving it from Schedule I (same category as heroin and LSD, no medical use allowed) down to Schedule III. That might sound like bureaucratic noise, but it actually matters a lot for the industry.

Right now, cannabis is stuck in this weird legal limbo. It's legal in tons of states, but federally illegal. That means companies can't move product across state lines efficiently, and they get absolutely hammered by Section 280E of the tax code - basically they can't deduct normal business expenses. If rescheduling happens, that changes everything. Companies could suddenly operate more efficiently, slash their tax burden, and actually scale properly. A company like Tilray, which is Canadian-based and can't even legally sell cannabis in the U.S. right now, could finally enter the American market directly.

Looking at the valuations, there's definitely something interesting here. Tilray's market cap is around $1.8 billion now, which is insane compared to the $17 billion it hit back in 2021. It's trading at 1.8x trailing sales and a price-to-book of 1.2. Investors are pricing in basically zero upside, which makes sense given the uncertainty. But if reform actually happens, that discount could evaporate fast.

The real question though - will pot stocks ever recover if we keep waiting for reform that might never come? That's the trap. The government has dangled legalization carrots before. Promising bills have come and gone with nothing to show for it. We could be looking at years of waiting, or it could never happen at all.

Honestly, I think these are only plays for people with serious risk tolerance who can afford to sit on them for years without freaking out. The valuations are beaten down enough that if reform does hit, you could see some real gains. But that's a big if. Most people are probably better off just watching from the sidelines and seeing if anything actually materializes before jumping back in. The recovery narrative looks good on paper, but timing it right? That's the hard part.